ATF2 (activating transcription factor 2) is a multifunctional transcription factor that regulates diverse cellular processes through both nuclear and cytoplasmic mechanisms 1. In the nucleus, ATF2 binds to CRE and AP-1 consensus sequences to control genes involved in anti-apoptosis, cell growth, and DNA damage response, while exhibiting histone acetyltransferase activity toward H2B and H4 histones. ATF2 phosphorylation by ATM mediates DNA damage checkpoint control and MRN complex recruitment to irradiation-induced foci 1. In the cytoplasm, ATF2 can promote cell death by perturbing mitochondrial complexes. ATF2 demonstrates context-dependent roles in disease. In gastric cancer, elevated ATF2 expression predicts poor prognosis and inhibits sorafenib-induced ferroptosis by transcriptionally activating HSPH1, which stabilizes the cystine/glutamate transporter SLC7A11 2. Similarly, in laryngeal squamous cell carcinoma, ATF2 suppresses ferroptosis through CHAC1 regulation, promoting lymphatic metastasis 3. Conversely, ATF2 has protective roles: in liver fibrosis, p38 MAPK-phosphorylated ATF2 mediates hepatocyte-derived extracellular vesicle-induced hepatic stellate cell activation 4, while MG53-mediated ATF2 ubiquitination reduces TLR4 expression to protect against septic cardiac dysfunction 5. SIRT6-mediated lysine demyristoylation of ATF2 promotes endothelial barrier integrity through PRKCD/VE-cadherin signaling 6. These findings establish ATF2 as a paradigmatic example of transcription factor complexity with tissue- and context-dependent functions in health and disease 1.